- Silo Wellness (SILO) has partnered with Mushe Inc. to establish the first brick and mortar psychedelic and functional mushroom shop in the Western Hemisphere
- The retail location will be located in Jamaica, where Silo Wellness currently operates
- The mission of Silo Wellness is to improve health and wellness through the development of psychedelic medicine
- Silo Wellness Inc. (SILO) is up 2.94 per cent, trading at $0.175 per share
Silo Wellness (SILO) has partnered with Mushe Inc to open the first brick and mortar mushroom shop in the Western Hemisphere.
The retail location will be located in Jamaica, where Silo Wellness currently operates.
Through this joint venture, Silo Wellness and Mushe will build out and operate a “smart shop” retail establishment specializing in the sale of functional and psychoactive mushroom products such as tinctures, capsules, topicals, and edibles, as well as boutique literature and accessories.
Douglas K. Gordon, CEO of Silo Wellness, commented on the partnership.
“As a company, we are very bullish about the high-potential functional mushroom category and the psychedelics sector as a whole. We continue to invest in and expand our operations in Jamaica, the only country where the cultivation, extraction and sale of psilocybin mushrooms is permissible,” he stated.
Jamaica is considered the epicenter of the psychedelic mushroom movement in the Western Hemisphere, positioning the island nation to directly benefit from wellness tourism as well as sales of psychedelic mushrooms.
“In Silo Wellness, we’ve found a partner aligned with our mission to educate consumers about the healing powers of psychedelics and make mushroom-based wellness products and experiences more available,” commented Jonathan Rakic, COO of Mushe.
He added, “We look forward to introducing Jamaican residents and tourists to the wide-ranging health and wellness benefits of functional and psychedelic mushrooms – one smart shop at a time.”
The mission of Silo Wellness is to improve health and wellness through the development of psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics.
Silo Wellness Inc. (SILO) is up 2.94 per cent, trading at $0.175 per share as of 9:30 am ET.